Wanbury Reports Strong Financial Results, Indicating Positive Trends and Improved Liquidity in August 2025

Wanbury, a microcap company in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending June 2025. The results, declared on August 4, 2025, indicate a notable shift in the company's evaluation, with a revision in its score reflecting recent performance metrics. The financial data reveals that Wanbury's Profit Before Tax (PBT) for the quarter reached Rs 13.26 crore, marking a significant growth compared to the average PBT of the previous four quarters, which stood at Rs 6.08 crore. This trend suggests a robust near-term outlook for PBT. Similarly, the Profit After Tax (PAT) also demonstrated strong performance, amounting to Rs 13.49 crore, which is a considerable increase from the average PAT of Rs 7.64 crore over the same period. Additionally, Wanbury's net sales for the latest six months totaled Rs 335.18 crore, reflecting a year-on-year growth of 23.90%. The company's cash and cash equivalents have reached their highest level in the last three years, totaling Rs 12.83 crore, indicating an improvement in short-term liquidity. Overall, these financial results highlight positive trends for Wanbury, leading to an adjustment in evaluation. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.